How Cytomegalovirus Retinitis Medications Work

Cytomegalovirus retinitis is a serious viral infection that affects the retina, often in individuals with weakened immune systems. The gold standard medication for treating this condition is Ganciclovir, an antiviral drug.

Gold Standard Medication: Ganciclovir

• How it works: Ganciclovir inhibits viral replication by interfering with the viral DNA polymerase, thereby preventing the virus from multiplying and causing further damage to the retina.
• Administration: Ganciclovir is typically administered intravenously or orally in a dose of 5 mg/kg/day for 21 days, followed by maintenance therapy.

Alternative Medications

• Foscarnet: Another antiviral medication that works by inhibiting viral replication and is used as an alternative to Ganciclovir in patients who cannot tolerate it or have resistant strains of the virus.
• Cidofovir: An antiviral medication that is also used as an alternative to Ganciclovir, particularly in patients with HIV/AIDS-related CMV retinitis.
• Valganciclovir: A prodrug of Ganciclovir that is orally administered and converted into its active form in the body. It is used as an alternative to intravenous Ganciclovir for patients who require long-term maintenance therapy.

Importance of Adherence

It is essential for patients with cytomegalovirus retinitis to adhere strictly to their medication regimen, as non-adherence can lead to treatment failure and progression of the disease. Regular monitoring by an ophthalmologist is also crucial to assess the effectiveness of the treatment and make any necessary adjustments.